View Financial HealthMegaMD 配当と自社株買い配当金 基準チェック /36MegaMD配当を支払う会社であり、現在の利回りは4.34%で、収益によって十分にカバーされています。主要情報4.3%配当利回りn/aバイバック利回り総株主利回りn/a将来の配当利回りn/a配当成長6.8%次回配当支払日n/a配当落ち日n/a一株当たり配当金n/a配当性向42%最近の配当と自社株買いの更新お知らせ • Mar 13MegaMD Co., Ltd. announces Annual dividendMegaMD Co., Ltd. announced Annual dividend of KRW 60.0000 per share, ex-date on March 26, 2026 and record date on March 27, 2026.Upcoming Dividend • Dec 21Upcoming dividend of ₩150 per shareEligible shareholders must have bought the stock before 28 December 2022. Payment date: 17 April 2023. Payout ratio is on the higher end at 91%, and the cash payout ratio is above 100%. Trailing yield: 5.0%. Within top quartile of South Korean dividend payers (3.3%). Higher than average of industry peers (3.4%).Upcoming Dividend • Dec 22Upcoming dividend of ₩100.00 per shareEligible shareholders must have bought the stock before 29 December 2021. Payment date: 11 April 2022. Payout ratio is a comfortable 33% and this is well supported by cash flows. Trailing yield: 2.2%. Lower than top quartile of South Korean dividend payers (2.4%). In line with average of industry peers (2.3%).分析記事 • Dec 24Read This Before Considering MegaMD Co., Ltd. (KOSDAQ:133750) For Its Upcoming ₩50.00 DividendMegaMD Co., Ltd. ( KOSDAQ:133750 ) is about to trade ex-dividend in the next 3 days. If you purchase the stock on or...Upcoming Dividend • Dec 22Upcoming Dividend of ₩50.00 Per ShareWill be paid on the 10th of April to those who are registered shareholders by the 29th of December. The trailing yield of 1.2% is below the top quartile of South Korean dividend payers (2.6%), and is lower than industry peers (3.2%).すべての更新を表示Recent updatesBuy Or Sell Opportunity • Jun 01Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 25% to ₩1,406. The fair value is estimated to be ₩1,765, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 28% over the last 3 years. Earnings per share has grown by 11%.お知らせ • Mar 14MegaMD Co., Ltd., Annual General Meeting, Mar 27, 2026MegaMD Co., Ltd., Annual General Meeting, Mar 27, 2026, at 10:30 Tokyo Standard Time. Location: conference room, 81, banpo-daero, seocho-gu, seoul South Koreaお知らせ • Mar 13MegaMD Co., Ltd. announces Annual dividendMegaMD Co., Ltd. announced Annual dividend of KRW 60.0000 per share, ex-date on March 26, 2026 and record date on March 27, 2026.New Risk • Mar 03New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 27% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported June 2025 fiscal period end). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Market cap is less than US$100m (₩42.2b market cap, or US$28.9m).Buy Or Sell Opportunity • Sep 10Now 21% overvaluedOver the last 90 days, the stock has fallen 11% to ₩2,005. The fair value is estimated to be ₩1,663, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 28% over the last 3 years. Earnings per share has grown by 11%.New Risk • May 20New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 24% per year over the past 5 years. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (8.8% average weekly change). Large one-off items impacting financial results. Market cap is less than US$100m (₩46.4b market cap, or US$33.3m).New Risk • Apr 10New minor risk - Dividend sustainabilityThe company has an unstable dividend paying track record. The dividend has had an annual drop of over 20% in the past. Dividend yield: 2.2% This is considered a minor risk. If the company has cut or reduced its dividend in the past, it may be a sign that the underlying business is too cyclical to consistently maintain or grow the dividend over the long-term. It may also indicate the company prioritizes other outcomes instead of maintaining the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 24% per year over the past 5 years. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results. Market cap is less than US$100m (₩56.8b market cap, or US$38.9m).分析記事 • Apr 08MegaMD Co., Ltd.'s (KOSDAQ:133750) 27% Price Boost Is Out Of Tune With RevenuesThe MegaMD Co., Ltd. ( KOSDAQ:133750 ) share price has done very well over the last month, posting an excellent gain of...Valuation Update With 7 Day Price Move • Apr 04Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₩2,435, the stock trades at a trailing P/E ratio of 14.2x. Average trailing P/E is 10x in the Consumer Services industry in South Korea. Total loss to shareholders of 33% over the past three years.分析記事 • Mar 28MegaMD's (KOSDAQ:133750) Solid Earnings Are Supported By Other Strong FactorsMegaMD Co., Ltd. ( KOSDAQ:133750 ) announced strong profits, but the stock was stagnant. We did some digging, and we...New Risk • Mar 28New major risk - Revenue and earnings growthEarnings have declined by 24% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 24% per year over the past 5 years. Minor Risks Large one-off items impacting financial results. Market cap is less than US$100m (₩47.4b market cap, or US$32.3m).お知らせ • Mar 14MegaMD Co., Ltd., Annual General Meeting, Mar 28, 2025MegaMD Co., Ltd., Annual General Meeting, Mar 28, 2025, at 10:30 Tokyo Standard Time. Location: conference room, 81, banpo-daero, seocho-gu, seoul South KoreaValuation Update With 7 Day Price Move • Dec 11Investor sentiment improves as stock rises 26%After last week's 26% share price gain to ₩2,425, the stock trades at a trailing P/E ratio of 24.8x. Average trailing P/E is 11x in the Consumer Services industry in South Korea. Total loss to shareholders of 50% over the past three years.分析記事 • Nov 13MegaMD (KOSDAQ:133750) Is Looking To Continue Growing Its Returns On CapitalWhat are the early trends we should look for to identify a stock that could multiply in value over the long term...Valuation Update With 7 Day Price Move • Aug 26Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₩2,080, the stock trades at a trailing P/E ratio of 36.2x. Average trailing P/E is 11x in the Consumer Services industry in South Korea. Total loss to shareholders of 57% over the past three years.Buy Or Sell Opportunity • Aug 16Now 28% overvaluedOver the last 90 days, the stock has fallen 6.9% to ₩2,440. The fair value is estimated to be ₩1,900, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 30% over the last 3 years. Meanwhile, the company has become profitable.分析記事 • Aug 08A Look At The Intrinsic Value Of MegaMD Co., Ltd. (KOSDAQ:133750)Key Insights Using the 2 Stage Free Cash Flow to Equity, MegaMD fair value estimate is ₩1,874 MegaMD's ₩1,908 share...Buy Or Sell Opportunity • Jul 08Now 26% overvaluedOver the last 90 days, the stock has fallen 13% to ₩2,155. The fair value is estimated to be ₩1,711, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 30% over the last 3 years. Meanwhile, the company has become profitable.分析記事 • Apr 18Some MegaMD Co., Ltd. (KOSDAQ:133750) Shareholders Look For Exit As Shares Take 25% PoundingMegaMD Co., Ltd. ( KOSDAQ:133750 ) shareholders won't be pleased to see that the share price has had a very rough...分析記事 • Feb 26MegaMD Co., Ltd.'s (KOSDAQ:133750) Popularity With Investors Is Under Threat From OverpricingWhen close to half the companies in the Consumer Services industry in Korea have price-to-sales ratios (or "P/S") below...New Risk • Nov 27New major risk - Revenue and earnings growthEarnings have declined by 1.7% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 1.7% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (10% average weekly change). Market cap is less than US$100m (₩61.4b market cap, or US$47.1m).New Risk • Nov 08New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (8.9% average weekly change). Market cap is less than US$100m (₩56.1b market cap, or US$43.0m).Upcoming Dividend • Dec 21Upcoming dividend of ₩150 per shareEligible shareholders must have bought the stock before 28 December 2022. Payment date: 17 April 2023. Payout ratio is on the higher end at 91%, and the cash payout ratio is above 100%. Trailing yield: 5.0%. Within top quartile of South Korean dividend payers (3.3%). Higher than average of industry peers (3.4%).Buying Opportunity • Aug 22Now 20% undervaluedOver the last 90 days, the stock is up 16%. The fair value is estimated to be ₩4,661, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Meanwhile, the company has become profitable.Valuation Update With 7 Day Price Move • Aug 16Investor sentiment improved over the past weekAfter last week's 27% share price gain to ₩4,130, the stock trades at a trailing P/E ratio of 13.5x. Average trailing P/E is 12x in the Consumer Services industry in South Korea. Total returns to shareholders of 135% over the past three years.Valuation Update With 7 Day Price Move • Jul 21Investor sentiment improved over the past weekAfter last week's 32% share price gain to ₩3,590, the stock trades at a trailing P/E ratio of 11.8x. Average trailing P/E is 11x in the Consumer Services industry in South Korea. Total returns to shareholders of 87% over the past three years.Valuation Update With 7 Day Price Move • Jun 15Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to ₩2,785, the stock trades at a trailing P/E ratio of 9.1x. Average trailing P/E is 12x in the Consumer Services industry in South Korea. Total returns to shareholders of 35% over the past three years.Valuation Update With 7 Day Price Move • Dec 23Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to ₩4,445, the stock trades at a trailing P/E ratio of 14.7x. Average trailing P/E is 14x in the Consumer Services industry in South Korea. Total returns to shareholders of 99% over the past three years.Upcoming Dividend • Dec 22Upcoming dividend of ₩100.00 per shareEligible shareholders must have bought the stock before 29 December 2021. Payment date: 11 April 2022. Payout ratio is a comfortable 33% and this is well supported by cash flows. Trailing yield: 2.2%. Lower than top quartile of South Korean dividend payers (2.4%). In line with average of industry peers (2.3%).Reported Earnings • Nov 13Third quarter 2021 earnings released: EPS ₩151 (vs ₩117 in 3Q 2020)The company reported a decent third quarter result with improved earnings and profit margins, although revenues were weaker. Third quarter 2021 results: Revenue: ₩20.1b (down 6.3% from 3Q 2020). Net income: ₩3.34b (up 31% from 3Q 2020). Profit margin: 17% (up from 12% in 3Q 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 95% per year but the company’s share price has only increased by 25% per year, which means it is significantly lagging earnings growth.Valuation Update With 7 Day Price Move • Jul 08Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₩7,200, the stock trades at a trailing P/E ratio of 25.5x. Average trailing P/E is 22x in the Consumer Services industry in South Korea. Total returns to shareholders of 156% over the past three years.Valuation Update With 7 Day Price Move • Apr 15Investor sentiment improved over the past weekAfter last week's 37% share price gain to ₩5,870, the stock trades at a trailing P/E ratio of 26.2x. Average trailing P/E is 22x in the Consumer Services industry in South Korea. Total returns to shareholders of 139% over the past three years.分析記事 • Apr 05Is MegaMD Co., Ltd. (KOSDAQ:133750) The Right Choice For A Smart Dividend Investor?Could MegaMD Co., Ltd. ( KOSDAQ:133750 ) be an attractive dividend share to own for the long haul? Investors are often...分析記事 • Mar 09Is MegaMD Co., Ltd.'s (KOSDAQ:133750) Recent Price Movement Underpinned By Its Weak Fundamentals?MegaMD (KOSDAQ:133750) has had a rough three months with its share price down 11%. It seems that the market might have...分析記事 • Feb 08MegaMD (KOSDAQ:133750) Shareholders Booked A 44% Gain In The Last Three YearsBy buying an index fund, investors can approximate the average market return. But many of us dare to dream of bigger...Is New 90 Day High Low • Jan 28New 90-day low: ₩3,610The company is down 5.0% from its price of ₩3,785 on 30 October 2020. The South Korean market is up 32% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Consumer Services industry, which is up 4.0% over the same period.分析記事 • Jan 14What Do The Returns On Capital At MegaMD (KOSDAQ:133750) Tell Us?If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Ideally, a...分析記事 • Dec 24Read This Before Considering MegaMD Co., Ltd. (KOSDAQ:133750) For Its Upcoming ₩50.00 DividendMegaMD Co., Ltd. ( KOSDAQ:133750 ) is about to trade ex-dividend in the next 3 days. If you purchase the stock on or...Upcoming Dividend • Dec 22Upcoming Dividend of ₩50.00 Per ShareWill be paid on the 10th of April to those who are registered shareholders by the 29th of December. The trailing yield of 1.2% is below the top quartile of South Korean dividend payers (2.6%), and is lower than industry peers (3.2%).分析記事 • Dec 08Is MegaMD Co., Ltd. (KOSDAQ:133750) A Great Dividend Stock?Today we'll take a closer look at MegaMD Co., Ltd. ( KOSDAQ:133750 ) from a dividend investor's perspective. Owning a...Valuation Update With 7 Day Price Move • Nov 18Market bids up stock over the past weekAfter last week's 26% share price gain to ₩4,610, the stock is trading at a trailing P/E ratio of 36x, up from the previous P/E ratio of 28.6x. This compares to an average P/E of 18x in the Consumer Services industry in South Korea. Total returns to shareholders over the past three years are 73%.分析記事 • Nov 17Are MegaMD's (KOSDAQ:133750) Statutory Earnings A Good Guide To Its Underlying Profitability?Statistically speaking, it is less risky to invest in profitable companies than in unprofitable ones. Having said...決済の安定と成長配当データの取得安定した配当: A133750は 10 年未満配当金を支払っており、この間、支払額は 変動性 が高かった。増加する配当: A133750の配当金は増加していますが、同社は7年間しか配当金を支払っていません。配当利回り対市場MegaMD 配当利回り対市場A133750 配当利回りは市場と比べてどうか？セグメント配当利回り会社 (A133750)4.3%市場下位25% (KR)1.1%市場トップ25% (KR)4.1%業界平均 (Consumer Services)6.8%アナリスト予想 (A133750) (最長3年)n/a注目すべき配当: A133750の配当金 ( 4.34% ) はKR市場の配当金支払者の下位 25% ( 1.13% ) よりも高くなっています。高配当: A133750の配当金 ( 4.34% ) はKR市場 ( 4.1% ) の配当支払者の中で上位 25% に入っています。株主への利益配当収益カバレッジ: A133750の 配当性向 ( 42.2% ) はかなり低いため、配当金の支払いは利益によって十分にカバーされます。株主配当金キャッシュフローカバレッジ: A133750の 現金配当性向 を計算して、配当金の支払いがキャッシュフローでカバーされているかどうかを判断するにはデータが不十分です。高配当企業の発掘7D1Y7D1Y7D1YKR 市場の強力な配当支払い企業。View Management企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/08 23:31終値2026/06/08 00:00収益2025/06/30年間収益2024/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋MegaMD Co., Ltd. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Mar 13MegaMD Co., Ltd. announces Annual dividendMegaMD Co., Ltd. announced Annual dividend of KRW 60.0000 per share, ex-date on March 26, 2026 and record date on March 27, 2026.
Upcoming Dividend • Dec 21Upcoming dividend of ₩150 per shareEligible shareholders must have bought the stock before 28 December 2022. Payment date: 17 April 2023. Payout ratio is on the higher end at 91%, and the cash payout ratio is above 100%. Trailing yield: 5.0%. Within top quartile of South Korean dividend payers (3.3%). Higher than average of industry peers (3.4%).
Upcoming Dividend • Dec 22Upcoming dividend of ₩100.00 per shareEligible shareholders must have bought the stock before 29 December 2021. Payment date: 11 April 2022. Payout ratio is a comfortable 33% and this is well supported by cash flows. Trailing yield: 2.2%. Lower than top quartile of South Korean dividend payers (2.4%). In line with average of industry peers (2.3%).
分析記事 • Dec 24Read This Before Considering MegaMD Co., Ltd. (KOSDAQ:133750) For Its Upcoming ₩50.00 DividendMegaMD Co., Ltd. ( KOSDAQ:133750 ) is about to trade ex-dividend in the next 3 days. If you purchase the stock on or...
Upcoming Dividend • Dec 22Upcoming Dividend of ₩50.00 Per ShareWill be paid on the 10th of April to those who are registered shareholders by the 29th of December. The trailing yield of 1.2% is below the top quartile of South Korean dividend payers (2.6%), and is lower than industry peers (3.2%).
Buy Or Sell Opportunity • Jun 01Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 25% to ₩1,406. The fair value is estimated to be ₩1,765, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 28% over the last 3 years. Earnings per share has grown by 11%.
お知らせ • Mar 14MegaMD Co., Ltd., Annual General Meeting, Mar 27, 2026MegaMD Co., Ltd., Annual General Meeting, Mar 27, 2026, at 10:30 Tokyo Standard Time. Location: conference room, 81, banpo-daero, seocho-gu, seoul South Korea
お知らせ • Mar 13MegaMD Co., Ltd. announces Annual dividendMegaMD Co., Ltd. announced Annual dividend of KRW 60.0000 per share, ex-date on March 26, 2026 and record date on March 27, 2026.
New Risk • Mar 03New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 27% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported June 2025 fiscal period end). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Market cap is less than US$100m (₩42.2b market cap, or US$28.9m).
Buy Or Sell Opportunity • Sep 10Now 21% overvaluedOver the last 90 days, the stock has fallen 11% to ₩2,005. The fair value is estimated to be ₩1,663, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 28% over the last 3 years. Earnings per share has grown by 11%.
New Risk • May 20New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 24% per year over the past 5 years. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (8.8% average weekly change). Large one-off items impacting financial results. Market cap is less than US$100m (₩46.4b market cap, or US$33.3m).
New Risk • Apr 10New minor risk - Dividend sustainabilityThe company has an unstable dividend paying track record. The dividend has had an annual drop of over 20% in the past. Dividend yield: 2.2% This is considered a minor risk. If the company has cut or reduced its dividend in the past, it may be a sign that the underlying business is too cyclical to consistently maintain or grow the dividend over the long-term. It may also indicate the company prioritizes other outcomes instead of maintaining the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 24% per year over the past 5 years. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results. Market cap is less than US$100m (₩56.8b market cap, or US$38.9m).
分析記事 • Apr 08MegaMD Co., Ltd.'s (KOSDAQ:133750) 27% Price Boost Is Out Of Tune With RevenuesThe MegaMD Co., Ltd. ( KOSDAQ:133750 ) share price has done very well over the last month, posting an excellent gain of...
Valuation Update With 7 Day Price Move • Apr 04Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₩2,435, the stock trades at a trailing P/E ratio of 14.2x. Average trailing P/E is 10x in the Consumer Services industry in South Korea. Total loss to shareholders of 33% over the past three years.
分析記事 • Mar 28MegaMD's (KOSDAQ:133750) Solid Earnings Are Supported By Other Strong FactorsMegaMD Co., Ltd. ( KOSDAQ:133750 ) announced strong profits, but the stock was stagnant. We did some digging, and we...
New Risk • Mar 28New major risk - Revenue and earnings growthEarnings have declined by 24% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 24% per year over the past 5 years. Minor Risks Large one-off items impacting financial results. Market cap is less than US$100m (₩47.4b market cap, or US$32.3m).
お知らせ • Mar 14MegaMD Co., Ltd., Annual General Meeting, Mar 28, 2025MegaMD Co., Ltd., Annual General Meeting, Mar 28, 2025, at 10:30 Tokyo Standard Time. Location: conference room, 81, banpo-daero, seocho-gu, seoul South Korea
Valuation Update With 7 Day Price Move • Dec 11Investor sentiment improves as stock rises 26%After last week's 26% share price gain to ₩2,425, the stock trades at a trailing P/E ratio of 24.8x. Average trailing P/E is 11x in the Consumer Services industry in South Korea. Total loss to shareholders of 50% over the past three years.
分析記事 • Nov 13MegaMD (KOSDAQ:133750) Is Looking To Continue Growing Its Returns On CapitalWhat are the early trends we should look for to identify a stock that could multiply in value over the long term...
Valuation Update With 7 Day Price Move • Aug 26Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₩2,080, the stock trades at a trailing P/E ratio of 36.2x. Average trailing P/E is 11x in the Consumer Services industry in South Korea. Total loss to shareholders of 57% over the past three years.
Buy Or Sell Opportunity • Aug 16Now 28% overvaluedOver the last 90 days, the stock has fallen 6.9% to ₩2,440. The fair value is estimated to be ₩1,900, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 30% over the last 3 years. Meanwhile, the company has become profitable.
分析記事 • Aug 08A Look At The Intrinsic Value Of MegaMD Co., Ltd. (KOSDAQ:133750)Key Insights Using the 2 Stage Free Cash Flow to Equity, MegaMD fair value estimate is ₩1,874 MegaMD's ₩1,908 share...
Buy Or Sell Opportunity • Jul 08Now 26% overvaluedOver the last 90 days, the stock has fallen 13% to ₩2,155. The fair value is estimated to be ₩1,711, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 30% over the last 3 years. Meanwhile, the company has become profitable.
分析記事 • Apr 18Some MegaMD Co., Ltd. (KOSDAQ:133750) Shareholders Look For Exit As Shares Take 25% PoundingMegaMD Co., Ltd. ( KOSDAQ:133750 ) shareholders won't be pleased to see that the share price has had a very rough...
分析記事 • Feb 26MegaMD Co., Ltd.'s (KOSDAQ:133750) Popularity With Investors Is Under Threat From OverpricingWhen close to half the companies in the Consumer Services industry in Korea have price-to-sales ratios (or "P/S") below...
New Risk • Nov 27New major risk - Revenue and earnings growthEarnings have declined by 1.7% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 1.7% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (10% average weekly change). Market cap is less than US$100m (₩61.4b market cap, or US$47.1m).
New Risk • Nov 08New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (8.9% average weekly change). Market cap is less than US$100m (₩56.1b market cap, or US$43.0m).
Upcoming Dividend • Dec 21Upcoming dividend of ₩150 per shareEligible shareholders must have bought the stock before 28 December 2022. Payment date: 17 April 2023. Payout ratio is on the higher end at 91%, and the cash payout ratio is above 100%. Trailing yield: 5.0%. Within top quartile of South Korean dividend payers (3.3%). Higher than average of industry peers (3.4%).
Buying Opportunity • Aug 22Now 20% undervaluedOver the last 90 days, the stock is up 16%. The fair value is estimated to be ₩4,661, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Meanwhile, the company has become profitable.
Valuation Update With 7 Day Price Move • Aug 16Investor sentiment improved over the past weekAfter last week's 27% share price gain to ₩4,130, the stock trades at a trailing P/E ratio of 13.5x. Average trailing P/E is 12x in the Consumer Services industry in South Korea. Total returns to shareholders of 135% over the past three years.
Valuation Update With 7 Day Price Move • Jul 21Investor sentiment improved over the past weekAfter last week's 32% share price gain to ₩3,590, the stock trades at a trailing P/E ratio of 11.8x. Average trailing P/E is 11x in the Consumer Services industry in South Korea. Total returns to shareholders of 87% over the past three years.
Valuation Update With 7 Day Price Move • Jun 15Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to ₩2,785, the stock trades at a trailing P/E ratio of 9.1x. Average trailing P/E is 12x in the Consumer Services industry in South Korea. Total returns to shareholders of 35% over the past three years.
Valuation Update With 7 Day Price Move • Dec 23Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to ₩4,445, the stock trades at a trailing P/E ratio of 14.7x. Average trailing P/E is 14x in the Consumer Services industry in South Korea. Total returns to shareholders of 99% over the past three years.
Upcoming Dividend • Dec 22Upcoming dividend of ₩100.00 per shareEligible shareholders must have bought the stock before 29 December 2021. Payment date: 11 April 2022. Payout ratio is a comfortable 33% and this is well supported by cash flows. Trailing yield: 2.2%. Lower than top quartile of South Korean dividend payers (2.4%). In line with average of industry peers (2.3%).
Reported Earnings • Nov 13Third quarter 2021 earnings released: EPS ₩151 (vs ₩117 in 3Q 2020)The company reported a decent third quarter result with improved earnings and profit margins, although revenues were weaker. Third quarter 2021 results: Revenue: ₩20.1b (down 6.3% from 3Q 2020). Net income: ₩3.34b (up 31% from 3Q 2020). Profit margin: 17% (up from 12% in 3Q 2020). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 95% per year but the company’s share price has only increased by 25% per year, which means it is significantly lagging earnings growth.
Valuation Update With 7 Day Price Move • Jul 08Investor sentiment improved over the past weekAfter last week's 15% share price gain to ₩7,200, the stock trades at a trailing P/E ratio of 25.5x. Average trailing P/E is 22x in the Consumer Services industry in South Korea. Total returns to shareholders of 156% over the past three years.
Valuation Update With 7 Day Price Move • Apr 15Investor sentiment improved over the past weekAfter last week's 37% share price gain to ₩5,870, the stock trades at a trailing P/E ratio of 26.2x. Average trailing P/E is 22x in the Consumer Services industry in South Korea. Total returns to shareholders of 139% over the past three years.
分析記事 • Apr 05Is MegaMD Co., Ltd. (KOSDAQ:133750) The Right Choice For A Smart Dividend Investor?Could MegaMD Co., Ltd. ( KOSDAQ:133750 ) be an attractive dividend share to own for the long haul? Investors are often...
分析記事 • Mar 09Is MegaMD Co., Ltd.'s (KOSDAQ:133750) Recent Price Movement Underpinned By Its Weak Fundamentals?MegaMD (KOSDAQ:133750) has had a rough three months with its share price down 11%. It seems that the market might have...
分析記事 • Feb 08MegaMD (KOSDAQ:133750) Shareholders Booked A 44% Gain In The Last Three YearsBy buying an index fund, investors can approximate the average market return. But many of us dare to dream of bigger...
Is New 90 Day High Low • Jan 28New 90-day low: ₩3,610The company is down 5.0% from its price of ₩3,785 on 30 October 2020. The South Korean market is up 32% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Consumer Services industry, which is up 4.0% over the same period.
分析記事 • Jan 14What Do The Returns On Capital At MegaMD (KOSDAQ:133750) Tell Us?If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Ideally, a...
分析記事 • Dec 24Read This Before Considering MegaMD Co., Ltd. (KOSDAQ:133750) For Its Upcoming ₩50.00 DividendMegaMD Co., Ltd. ( KOSDAQ:133750 ) is about to trade ex-dividend in the next 3 days. If you purchase the stock on or...
Upcoming Dividend • Dec 22Upcoming Dividend of ₩50.00 Per ShareWill be paid on the 10th of April to those who are registered shareholders by the 29th of December. The trailing yield of 1.2% is below the top quartile of South Korean dividend payers (2.6%), and is lower than industry peers (3.2%).
分析記事 • Dec 08Is MegaMD Co., Ltd. (KOSDAQ:133750) A Great Dividend Stock?Today we'll take a closer look at MegaMD Co., Ltd. ( KOSDAQ:133750 ) from a dividend investor's perspective. Owning a...
Valuation Update With 7 Day Price Move • Nov 18Market bids up stock over the past weekAfter last week's 26% share price gain to ₩4,610, the stock is trading at a trailing P/E ratio of 36x, up from the previous P/E ratio of 28.6x. This compares to an average P/E of 18x in the Consumer Services industry in South Korea. Total returns to shareholders over the past three years are 73%.
分析記事 • Nov 17Are MegaMD's (KOSDAQ:133750) Statutory Earnings A Good Guide To Its Underlying Profitability?Statistically speaking, it is less risky to invest in profitable companies than in unprofitable ones. Having said...